Greenyn Biotechnology Co., Ltd (TPEX:6846)
Taiwan · Delayed Price · Currency is TWD 57.80
-0.60 (-1.03%)
Oct 30, 2026, 1:23 PM CST
Greenyn Biotechnology Market Cap
Greenyn Biotechnology has a market cap or net worth of 1.56 billion as of October 30, 2026. It is the 30,292nd most valuable company in the world and the 1,787th biggest in Taiwan. Its market cap has decreased by 21.04% in one year.
Market Cap
1.56B
Enterprise Value
n/a
Revenue
n/a
Global Rank
Country Rank
#1,787 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since April 19, 2022, Greenyn Biotechnology's market cap has decreased from 2.03B to 1.56B, a decrease of -23.00%. That is a compound annual growth rate of -5.60%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 1.56B | -21.36% |
| Dec 31, 2025 | 1.98B | -8.66% |
| Dec 31, 2024 | 2.17B | 2.47% |
| Dec 29, 2023 | 2.12B | 6.41% |
| Dec 30, 2022 | 1.99B | -1.69% |
| Apr 19, 2022 | 2.03B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Gwo Xi Stem Cell Applied Technology Co. , | 2.01B |
| G&E Herbal Biotechnology | 1.86B |
| U-Neuron Biomedical | 1.72B |
| Sunny Pharmtech | 1.64B |
| Anti-Microbial Savior BioteQ | 1.62B |
| Synbio Tech | 1.61B |
| Andros Pharmaceuticals Co.,Ltd | 1.53B |
| GenMont Biotech Incorporation | 1.47B |